Table 1.
Selected Baseline Characteristics.
| CHUM (Selective TATT) N = 69 |
CHUS (Ticagrelor-DAPT) N = 108 |
Unadjustedp-value | |
|---|---|---|---|
| Age (yrs) | 64.6 ± 13.6 | 62.2 ± 10.9 | 0.183 |
| Men | 49 (71%) | 79 (73%) | 0.863 |
| Diabetes | 17 (25%) | 10 (9%) | 0.009* |
| Hypertension | 37 (54%) | 41 (38%) | 0.045* |
| Dyslipidemia | 31 (45%) | 43 (40%) | 0.534 |
| BMI (kg/m2) | 27.1 ± 5.2 | 27.0 ± 4.2 | 0.898 |
| eGFR (mL/min) | 84.5 ± 35.2 | 100.7 ± 38.5 | 0.007* |
| Hemoglobin (g/L) | 142.3 ± 27.2 | 141.1 ± 16.3 | 0.706 |
| Stroke/TIA History | 2 (3%) | 2 (2%) | 0.641 |
| CHADS2 Score | 1 (0–2) | 0 (0–1) | 0.012* |
| CHA2DS2-VASC Score | 1 (1–3) | 1 (0–2) | 0.160 |
| HASBLED Score | 1 (0–2) | 1 (0–1) | 0.074 |
| Prior PCI | 11 (16%) | 1 (1%) | 0.0002* |
| Radial Access | 57 (83%) | 81 (75%) | 0.268 |
| FMC-Device Time (min) | 127 (101–178) | 97 (79–121) | <0.001* |
| FMC-Device ≤ 90 min | 15 (22%) | 43 (40%) | 0.021* |
| Drug-Eluting Stent Use | 45 (65%) | 84 (78%) | 0.083 |
| Procedural Success | 64 (93%) | 108 (100%) | 0.008* |
| Cardiac Arrest | 16 (23%) | 11 (10%) | 0.031* |
| LVEF | 39% ± 9% | 37% ± 9% | 0.892 |
| No. Dysf. Apical Segments | 4 (3–4) | 4 (4–4) | 0.469 |
| 1 Dysf. Segment | 1 (1%) | 6 (6%) | 0.293† |
| 2 Dysf. Segments | 9 (13%) | 11 (10%) | |
| 3 Dysf. Segments | 10 (15%) | 9 (8%) | |
| 4 Dysf. Segments | 49 (71%) | 82 (76%) |
BMI: Body mass index. eGFR: Estimate glomerular filtration rate (Cockcroft-Gault method). TIA: Transient ischemic attack. PCI: Percutaneous coronary intervention. FMC: First medical contact. LVEF: Left ventricular ejection fraction.
*p < 0.05. †Result for the Chi2 analysis of the number of affected apical segments.